When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
Older Diabetics Face Higher Heart Disease Risk from Air Pollution, New Study Warns Dirty air turns diabetes into a heart ...
Cardiovascular diseases (CVDs) account for approximately 19.8 million deaths annually, representing roughly 32% of all global mortality. Atherosclerosis is a lipid-driven, inflammatory process that ...
The FDA has approved a pill version of Novo Nordisk’s blockbuster drug Wegovy, giving the company the lead in the pharmaceutical industry pursuit of oral weight loss drugs while also providing ...
Cytokinetics, Incorporated CYTK announced that the FDA approved its lead pipeline candidate, aficamten, for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to ...
President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Watch in our video player above. Pharmaceutical companies Amgen, ...
President Donald Trump has signed an executive order making some big changes to marijuana policy, the most substantial since 1970. On Dec. 18, Trump ordered the government to stop classifying ...
Today is a good day for potheads, and a great one for the nation’s state-regulated marijuana businesses. In a historic move, the federal government will reclassify cannabis to a more lenient category.
Eli Lilly and Novo Nordisk — the dominant players in obesity drug development — each submitted a new weight-loss drug to the FDA for approval on Thursday. Eli Lilly’s LLY drug is called orforglipron.
After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...
Medicare drug price negotiations kick-started by the Biden administration will finally result in lower drug prices for seniors beginning Jan. 1. The Medicare-negotiated price cuts will apply to 10 ...